Home
About
Publications Trends
Recent Publications
Expert Search
Archive
immunosuppressive microenvironment
What Cells Contribute to the Immunosuppressive Microenvironment?
Several types of cells contribute to the immunosuppressive microenvironment:
T regulatory cells (Tregs)
: These cells suppress T cell activity and promote tumor tolerance.
Myeloid-derived suppressor cells (MDSCs)
: These cells inhibit the function of T cells and natural killer (NK) cells.
Tumor-associated macrophages (TAMs)
: These macrophages often promote tumor growth and suppress immune responses.
Cancer-associated fibroblasts (CAFs)
: These fibroblasts can produce molecules that suppress immune cell infiltration and function.
Frequently asked queries:
What is the Immunosuppressive Microenvironment?
Why is the Immunosuppressive Microenvironment Important in Cancer?
What Cells Contribute to the Immunosuppressive Microenvironment?
What Molecules are Involved in Immune Suppression?
How Does Hypoxia Contribute to Immune Suppression?
Why is Fentanyl Used in Cancer Pain Management?
What Resources Are Available for Employees and Employers?
Is it safe to travel during cancer treatment?
How Can Financial Counseling Help with Insurance Claims?
How Can a Fitness Trainer Personalize Exercise Plans for Cancer Patients?
What Happens After the Trial?
How Can Researchers Access and Use PDB Data?
What is Senescence Associated Secretory Phenotype (SASP)?
What Is the Future of ACT in Cancer Treatment?
What is the Connection Between Inflammation and Cancer?
What is Reusability in Cancer Research?
How Does Genomics Data Impact Clinical Decision-Making?
When is Aggressive Chemotherapy Used?
Why is Suicide a Concern Among Cancer Patients?
What are the Types of Hormone Therapy?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe